Latest News - Earnings & Financials

Thursday, May 04, 2017 | Earnings & Financials, Avedro

Avedro Launches Comprehensive Effort to Secure Coverage and Facilitate Reimbursement of FDA-Approved Corneal Cross-Linking Procedure

Avedro announced a comprehensive effort to secure commercial coverage and support reimbursement of Photrexa Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), Photrexa (ribofl…

Read the full story

Tuesday, May 02, 2017 | Earnings & Financials

LensGen Closes $21 Million Series A Financing to Advance Modular, Fluid-Optic Accommodating IOL

LensGen, a private company developing Juvene, the first modular, fluid-optic accommodating intraocular lens, has closed a $21 million Series A financing. The financing was led by the corporate venture…

Read the full story

Friday, April 28, 2017 | Earnings & Financials

Opthea Completes A$45 Million Capital Raising

Opthea announced the completion of its A$45 million capital raising launched on April 3, 2017. The proceeds from this offering enable the acceleration and diversification of the company's clinical…

Read the full story

Thursday, April 27, 2017 | Earnings & Financials, Avedro

Avedro Announces $42 Million in Funding to Support Commercial Expansion and Pipeline Development

Avedro announced that it secured a combined $42 million in equity and debt financing. The equity financing was led by HealthQuest Capital, with support from existing investors OrbiMed Advisors and Int…

Read the full story

Wednesday, April 26, 2017 | Earnings & Financials, Alcon

Novartis Pushes Pipeline But Keeps An Eye On Alcon

Investors reacted well to a decent first quarter from Novartis that suggested that the long-awaited turnaround in its Alcon eyecare division has begun. While there is still investment needed, especial…

Read the full story

Thursday, March 30, 2017 | Earnings & Financials, Valeant

Ackman: Investment in Valeant a 'Huge Mistake'

In his annual letter to investors of his hedge fund, Bill Ackman “deeply and profoundly” apologized for his investment in Valeant, a move that ultimately cost Pershing Square Capital Manag…

Read the full story

Wednesday, March 29, 2017 | Earnings & Financials, Allergan

Allergan's CEO Pay Plummets by 80%

After a 2016 that hit some bumps financially -- and one that didn’t feature the Pfizer-Allergan merger the companies had planned on -- Allergan CEO Brent Saunders’ pay is down. Way, way do…

Read the full story

Tuesday, March 21, 2017 | Earnings & Financials, ONL Therapeutics

ONL Therapeutics Receives Nearly $1 Million Grant from National Eye Institute for Continued Advancement of ONL1204 Program

ONL Therapeutics announced that the company has been awarded a Commercialization Readiness Pilot (CRP) grant of approximately $1 million from the National Eye Institute (NEI) to continue advancement o…

Read the full story

Friday, March 17, 2017 | Earnings & Financials, Retina, Aerpio Therapeutics

Aerpio Pharmaceuticals Raises $40 Million

Aerpio Pharmaceuticals, a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced the successful completion of its reverse merger transaction with Aerpi…

Read the full story

Tuesday, March 14, 2017 | Earnings & Financials, Valeant

Ackman Unloads Entire Stake in Valeant

After a long relationship that has seen the rapid rise and massive fall of Valeant’s stock price, Pershing Square Capital Management CEO Bill Ackman stated that his hedge fund has sold all its s…

Read the full story

Friday, March 10, 2017 | Earnings & Financials

Federal Insider Trading Trial Begins for Ex-Angel Player Doug DeCinces

An ex-Angel star who made more than a $1 million in investments related to a friend’s medical-device company appeared in federal court Thursday for the start of his insider-trading trial. A fede…

Read the full story

Wednesday, March 08, 2017 | Earnings & Financials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Provides Update on Products in Development

As part of its fourth quarter and full-year earnings results reporting, Aerie Pharmaceuticals provided updates on several of its products in clinical development, including: Rhopressa (netarsud…

Read the full story

Monday, February 20, 2017 | Earnings & Financials

Essilor to Launch Next Gen Varilux Lens Based on Fresh Approach to Product Development

Essilor is abandoning traditional methods of developing and designing products in favor of an innovative, customer-driven approach that has already yielded a new generation of Varilux progressive lens…

Read the full story

Friday, February 17, 2017 | Dry Eye, Earnings & Financials, Shire

Shire Provides Update on Early Xiidra Sales

As part of its fourth quarter and full-year earnings release on Thursday, Shire provided information about the early sales of its dry eye disease drug Xiidra (lifitegrast), which was launched in Augus…

Read the full story

Tuesday, February 14, 2017 | Earnings & Financials, Retina, Pixium Vision

Pixium Vision Receives NUB Innovation Reimbursement Status-1 for 150 Electrode IRIS II Bionic System in Germany

Pixium Vision announced that the German Institute for the Hospital Remuneration System (InEK) has granted NUB (Neue Untersuchungs- und Behandlungsmethoden) Status-1 for IRIS II, Pixium Vision’s …

Read the full story
Load More